NuScale is America’s contender in the race to build a commercial, nuclear small modular reactor (SMR). The company has two buyers for its product lined up. But the stock’s price seems to say that there is trouble ahead, especially after the recent release of a negative research report by a small short selling firm, Iceberg Research. Peak to trough the shares have fallen about 75% and since their initial $10 a share public offering via a merger with a special purpose acquisition company (SPAC) in May 2022 the shares (ticker SMR) have…
